Ophthalmologists James L Funderburgh, Ph.D. and Fatima Syed-Picard, Ph.D. from the University of Pittsburgh have devised a method for treating corneal blindness by utilizing dental pulp stem cells. The researchers harvested the stem cells from molars discarded during routine extraction and induced the cells to differentiate into keratocytes [corneal cells]. They then seeded the cells onto a nanofiber scaffold, allowing them to grow into fully developed, functional corneas capable of restoring eyesight.
Although corneal blindness affects millions of people worldwide, there is no cure for the disease. The most common treatment is grafting new corneas from cadavers, but this method is limited by a lack of donors and a high rate of rejection from the patient’s immune system. According to Dr. Funderburgh, “These studies provide promising data on the potential translation of DPSC as an autologous cell source for regenerative corneal therapies and possibly more,” Additionally, the use of autologous [the patient’s own] dental pulp stem cells removes the risk of immune rejection, while also eliminating the reliance on donors.
Dr. Funderburgh and Dr. Syed-Picard’s research is an example of the potential for stem cell regenerative medical therapies to effectively treat seemingly intractable and incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable dental pulp stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.